Bg pattern

ENTECAVIR KABI 1 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ENTECAVIR KABI 1 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Entecavir Kabi 1 mg film-coated tablets EFG

entecavir

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Entecavir Kabi and what is it used for
  2. What you need to know before you take Entecavir Kabi
  3. How to take Entecavir Kabi
  4. Possible side effects
  5. Storage of Entecavir Kabi
  6. Contents of the pack and other information

1. What is Entecavir Kabi and what is it used for

Entecavirisanantiviralmedicineusedtotreatchronic(long-term)hepatitisBvirus(HBV)infectioninadults.

Entecavir may be used in patients whose liver is damaged but still works adequately (compensated liver disease) and in patients whose liver is damaged and does not work adequately (decompensated liver disease).

Entecavirisalsousedtotreatchronic(long-term)HBVinfectioninchildrenandadolescentsfrom2tolessthan18yearsofage.

Entecavir may be used in children whose liver is damaged but still works adequately (compensated liver disease).

Hepatitis B virus infection can damage your liver. Entecavir reduces the amount of virus in your body and improves the condition of your liver.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Entecavir Kabi

Do not take Entecavir Kabi

  • youareallergictoentecavirortoanyoftheotheringredientsofthismedicine(listedinsection6).

Warnings and precautions

Tell your doctor or pharmacist before you start taking entecavir

  • Ifyouhaveeverhadkidneyproblems,tellyourdoctor.Thisisimportantbecauseentecavirisremovedfromthebodybythekidneysanditmaybenecessarytoadjustyourdoseortreatmentschedule.
  • Donotstoptakingentecavirwithoutconsultingyourdoctor,asyourhepatitismayworsenwhentreatmentisinterrupted.Whenyourtreatmentwithentecavirisinterrupted,yourdoctorwillmonitoryoucloselyandperformbloodtestsforseveralmonths.
  • Askyourdoctorifyourliverisworkingproperlyandifnot,aboutthepossibleeffectsthattreatmentwithentecavircouldhave.
  • IfyouarealsoinfectedwithHIV(humanimmunodeficiencyvirus),makesuretotellyourdoctor.YoumustnottakeentecavirforthetreatmentofyourhepatitisBinfectionunlessyouarealsotakingmedicinesforthetreatmentofHIVinfection,asotherwisetheeffectivenessoffuturetreatmentsforHIVmaybereduced.EntecavirwillnotcontrolyourHIVinfection.
  • TakingEntecavirwillnotpreventyoufrominfectingotherpeoplewithhepatitisBvirus(HBV)throughsexualcontactorbodyfluids(includingcontaminationofblood).Therefore,itisimportantthatyoutakeappropriateprecautionstopreventotherpeoplefromgettinginfectedwithHBV.AvaccineisavailabletoprotectpeopleatriskofinfectionwithHBV.
  • Entecavirbelongstoaclassofmedicinesthatcancauselacticacidosis(excesslacticacidinyourblood)andenlargementoftheliver.Symptomssuchasnausea,vomitingandabdominalpaincouldindicatethedevelopmentoflacticacidosis.Onoccasion,thisrarebutserioussideeffecthasbeenfatal.Lacticacidosisoccursmorefrequentlyinwomen,especiallyinthosewhoareoverweight.Yourdoctorwillmonitoryouregularlywhileyouaretakingthismedicine.
  • IfyouhavereceivedprevioustreatmentforchronichepatitisB,pleasetellyourdoctor.

Children and adolescents

Entecavir must not be used in children under 2 years of age or weighing less than 10 kg.

Taking Entecavir Kabi with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Taking Entecavir Kabi with food and drinks

In most cases, you can take entecavir with or without food. However, if you have received previous treatment with another medicine that contains lamivudine as the active ingredient, you should consider the following. If you have switched to entecavir because treatment with lamivudine was not successful, you should take entecavir on an empty stomach, once a day. If your liver disease is very advanced, your doctor will also instruct you on taking entecavir on an empty stomach.

An empty stomach means at least 2 hours after and 2 hours before the next meal.

Children and adolescents (from 2 to less than 18 years of age) can take entecavir with or without food.

Pregnancy, breast-feeding and fertility

Tell your doctor if you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby. The use of entecavir has not been shown to be safe during pregnancy. Entecavir should not be used during pregnancy unless clearly necessary, as determined by your doctor. It is important that women of childbearing age using entecavir use an effective method of contraception to prevent pregnancy.

You must not breast-feed while taking entecavir. If you are breast-feeding, tell your doctor. It is not known whether entecavir, the active ingredient of this medicine, is excreted in human milk.

Driving and using machines

Dizziness, fatigue and somnolence are common side effects that may affect your ability to drive and use machines. If you are affected, do not drive or operate machines.

Entecavir Kabi contains lactose and maltodextrin

This medicine contains lactose and maltodextrin (which contains glucose). If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

3. How to take Entecavir Kabi

Not all patients need to take the same dose of Entecavir Kabi.

Follow exactly the instructions of your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

For adultsthe recommended dose is 0.5 mg or 1 mg once a day (by mouth).

Your dose will depend on:

  • whether you have been treated for HBV infection before, and what medicine you received.
  • whether you have kidney problems. Your doctor may prescribe a lower dose or tell you to take it less often than once a day.
  • the condition of your liver.

For children and adolescents(from 2 to less than 18 years of age), your paediatrician will decide on the appropriate dose based on the child's body weight. 0.5 mg tablets are available and an oral solution of entecavir may also be available.

Always take the dose recommended by your doctor to ensure that the medicine is fully effective and to reduce the development of resistance to treatment. Take entecavir for as long as your doctor tells you. Your doctor will tell you when you should stop treatment.

Some patients must take this medicine on an empty stomach (see Entecavir Kabi with food and drinksin Section 2). If your doctor tells you to take this medicine on an empty stomach, an empty stomach means at least 2 hours after and 2 hours before the next meal.

If you take more Entecavir Kabi than you should

If you have taken more entecavir than you should, talk to a doctor or pharmacist immediately. If possible, show them the pack or this leaflet.

If you forget to take Entecavir Kabi

It is important that you do not miss any doses. If you miss a dose of Entecavir, take it as soon as possible, then take the next dose at the usual time. If it is almost time for your next dose, do not take the missed dose. Wait and take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

Do not stop taking Entecavir Kabi without consulting your doctor

Some people develop severe hepatitis symptoms when they stop taking entecavir. Tell your doctor immediately about any changes in symptoms you notice after stopping treatment.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Patients treated with entecavir have reported the following side effects:

Adults

Common (may affect up to 1 in 10 people)

  • headache, insomnia (inability to sleep), fatigue (extreme tiredness), dizziness, somnolence (drowsiness)
  • vomiting, diarrhoea, nausea, dyspepsia (indigestion)
  • increase in liver enzyme levels in the blood.

Uncommon (may affect up to 1 in 100 people)

  • skin rash
  • hair loss

Rare (may affect up to 1 in 1,000 people)

  • severe allergic reaction.

Children and adolescents

The side effects experienced in children and adolescents are similar to those experienced in adults as described above, with the following difference:

Very common(may affect more than 1 in 10 people):

  • low levels of neutrophils (a type of white blood cell that is important for fighting infections).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Entecavir Kabi

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Once the bottle is opened, the tablets should be used within 30 days.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Entecavir Kabi

Contents of Entecavir Kabi

  • The active substance is entecavir.

Each film-coated tablet of Entecavir Kabi 1.0 mg contains entecavir monohydrate equivalent to 1 mg of entecavir.

  • The other ingredients are:

Core of the tablet: lactose monohydrate, microcrystalline cellulose, crospovidone (type A), hydroxypropyl cellulose (type L), magnesium stearate

Film coating (pink): hypromellose, titanium dioxide (E171), polydextrose, talc, maltodextrin, medium-chain triglycerides, red iron oxide (E172), yellow iron oxide (E172).

Appearance of the product and pack size

Entecavir Kabi 1.0 mg film-coated tablets are pink, triangular tablets, marked with “1” on one side, with a mean size of 10.6 mm ± 0.2 mm and 4.5 mm ± 0.3 mm in thickness.

Entecavir Kabi is available in cardboard boxes containing OPA/ALU/PVC-Aluminium blisters or a white high-density polyethylene (HDPE) bottle with a child-resistant polypropylene cap and an induction seal.

Pack sizes:

30 tablets

30 x 1 tablets

90 tablets

90 x 1 tablets

Not all pack sizes may be marketed in your country.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Fresenius Kabi España, S.A.U.

Marina 16-18

08005 Barcelona

Spain

Manufacturer:

Pharmathen S.A.

6 Dervenakion Str

15351 Pallini (Athens)

Greece

Heumann Pharma GmbH & Co. Generica KG

Südwestpark 50

Nürnberg 90449

Germany

Pharmathen International S.A.

Industrial Park Sapes, Rodopi Prefecture, Block No.5

Rodopi 69300 Greece

This medicine is authorised in the Member States of the European Economic Area under the following names:

Denmark

Entecavir Pharmathen

United Kingdom

Entecavir

Germany

Entecavir Heumann 1 mg Filmtabletten

Italy

Entecavir Kabi

Spain

Entecavir Kabi 1.0 mg film-coated tablets EFG

Poland

Entecavir Synoptis

France

ENTECAVIR PHARMATHEN 1 mg, film-coated tablet

Date of last revision of this leaflet: August 2020

Detailed and up-to-date information on this product is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/

Online doctors for ENTECAVIR KABI 1 mg FILM-COATED TABLETS

Discuss questions about ENTECAVIR KABI 1 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ENTECAVIR KABI 1 mg FILM-COATED TABLETS?
ENTECAVIR KABI 1 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ENTECAVIR KABI 1 mg FILM-COATED TABLETS?
The active ingredient in ENTECAVIR KABI 1 mg FILM-COATED TABLETS is entecavir. This information helps identify medicines with the same composition but different brand names.
Who manufactures ENTECAVIR KABI 1 mg FILM-COATED TABLETS?
ENTECAVIR KABI 1 mg FILM-COATED TABLETS is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ENTECAVIR KABI 1 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ENTECAVIR KABI 1 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ENTECAVIR KABI 1 mg FILM-COATED TABLETS?
Other medicines with the same active substance (entecavir) include BARACLUDE 0.05 mg/mL ORAL SOLUTION, BARACLUDE 0.5 mg FILM-COATED TABLETS, BARACLUDE 1 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media